+171.1%
SLV vs THC
+1,421.6%
-1,250.6%
-57.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -1.1% | +1.0% | -0.1% |
| 7D | +5.1% | +3.7% | +1.4% | +4.8% |
| 30D | -12.9% | +9.0% | -22.0% | -13.4% |
| 3M | -16.1% | +10.4% | -26.5% | -16.6% |
| 6M | -33.2% | +45.7% | -78.8% | -34.9% |
| YTD | -27.2% | +42.6% | -69.8% | -29.1% |
| 1Y | +7.6% | +38.8% | -31.1% | +4.9% |
| 3Y | +122.3% | +418.8% | -296.5% | +99.4% |
| 5Y | +109.7% | +275.7% | -166.0% | +88.9% |
| All | +171.1% | +1,421.6% | -1,250.6% | +125.3% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling